During the past decade, Henry Ford Health System conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 14 clinical trials were completed, i.e. on average, 48.3% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 9 clinical trials were completed. i.e. 56.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Henry Ford Health System" #1 sponsor was "Gilead Sciences" with 6 trials, followed by "CymaBay Therapeutics, Inc." with 5 trials sponsored, "Henry Ford Health System" with 5 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "Harmony Biosciences, LLC" with 3 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Henry Ford Health System" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 1 trials as a collaborator and "Takeda Pharmaceuticals North America, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Henry Ford Health System" are "Insomnia" (4 trials), "Primary Biliary Cholangitis" (4 trials), "Ulcerative Colitis" (4 trials), "Chronic Hepatitis C" (3 trials) and "Eosinophilic Esophagitis" (3 trials). Many other conditions were trialed in "Henry Ford Health System" in a lesser frequency.

Most popular intervention types in "Henry Ford Health System" are "Drug" (35 trials), "Behavioral" (4 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "RBV" (4 trials), "APT-1011" (2 trials), "Cognitive Behavioral Therapy for Insomnia (CBTI)" (2 trials) and "Mirikizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Henry Ford Health System" are 35 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Henry Ford Health System". undefined are not yet recruiting, 9 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 19 completed trials in Henry Ford Health System, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Henry Ford Health System, 2 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".